Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, (1), CD003012

Active Placebos Versus Antidepressants for Depression

Affiliations
Review

Active Placebos Versus Antidepressants for Depression

J Moncrieff et al. Cochrane Database Syst Rev.

Abstract

Background: Although there is a consensus that antidepressants are effective in depression, placebo effects are also thought to be substantial. Side effects of antidepressants may reveal the identity of medication to participants or investigators and thus may bias the results of conventional trials using inert placebos. Using an 'active' placebo which mimics some of the side effects of antidepressants may help to counteract this potential bias.

Objectives: To investigate the efficacy of antidepressants when compared with 'active' placebos.

Search strategy: The Cochrane Collaboration Depression, Anxiety and Neurosis review groups's search strategy was used to search MEDLINE (1966-2000), PsychLIT (1980-2000) and EMBASE (1974-2000) and this was last done in July 2000. Reference lists from relevant articles and textbooks were searched and 12 specialist journals were handsearched up to 1996.

Selection criteria: Randomised and quasi randomised controlled trials comparing antidepressants with active placebos in people with depression.

Data collection and analysis: Since many different outcome measures were used a standard measure of effect was calculated for each trial. A subgroup analysis of inpatient and outpatient trials was conducted. Two reviewers independently assessed whether each trial met inclusion criteria.

Main results: Nine studies involving 751 participants were included. Two of them produced effect sizes which showed a consistent and statistically significant difference in favour of the active drug. Combining all studies produced a pooled estimate of effect of 0.39 standard deviations (confidence interval, 0.24 to 0.54) in favour of the antidepressant measured by improvement in mood. There was high heterogeneity due to one strongly positive trial. Sensitivity analysis omitting this trial reduced the pooled effect to 0.17 (0.00 to 0.34). The pooled effect for inpatient and outpatient trials was highly sensitive to decisions about which combination of data was included but inpatient trials produced the lowest effects.

Reviewer's conclusions: The more conservative estimates from the present analysis found that differences between antidepressants and active placebos were small. This suggests that unblinding effects may inflate the efficacy of antidepressants in trials using inert placebos. Further research into unblinding is warranted.

Update of

  • Antidepressants Using Active Placebos
    J Moncrieff et al. Cochrane Database Syst Rev (2), CD003012. PMID 11406060. - Review
    The more conservative estimates from the present analysis found that differences between antidepressants and active placebos were small. This suggests that unblinding eff …

Comment in

Similar articles

  • Antidepressants Using Active Placebos
    J Moncrieff et al. Cochrane Database Syst Rev (2), CD003012. PMID 11406060. - Review
    The more conservative estimates from the present analysis found that differences between antidepressants and active placebos were small. This suggests that unblinding eff …
  • Pharmacological Interventions for Somatoform Disorders in Adults
    M Kleinstäuber et al. Cochrane Database Syst Rev (11), CD010628. PMID 25379990. - Review
    The current review found very low-quality evidence for NGAs and low-quality evidence for NPs being effective in treating somatoform symptoms in adults when compared with …
  • Duloxetine Versus Other Anti-Depressive Agents for Depression
    A Cipriani et al. Cochrane Database Syst Rev 10, CD006533. PMID 23076926. - Review
    Duloxetine did not seem to provide a significant advantage in efficacy over other antidepressive agents for the acute-phase treatment of major depression. No differences …
  • Antidepressant Treatment for Postnatal Depression
    E Molyneaux et al. Cochrane Database Syst Rev (9), CD002018. PMID 25211400. - Review
    The evidence base for this review was very limited, with a small number of studies and little information on a number of important outcomes, particularly regarding potent …
  • Meta-analysis of Trials Comparing Antidepressants With Active Placebos
    J Moncrieff et al. Br J Psychiatry 172, 227-31; discussion 232-4. PMID 9614471. - Meta-Analysis
    Meta-analysis is very sensitive to decisions about exclusions. Previous general meta-analyses have found combined effect sizes in the range 0.4-0.8. The more conservative …
See all similar articles

Cited by 71 PubMed Central articles

See all "Cited by" articles

Substances

Feedback